Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial.

Khoa VuJiani ZhouAlexander EverhartNihar DesaiJeph HerrinAnupam B JenaJoseph S RossNilay D ShahPinar Karaca-Mandic

Published in: BMC nephrology (2021)

Physician specialty has a dominant role in prescribing decision, and that specializations with higher use of treatment (nephrologists) were more responsive to new evidence of unsafety and ineffectiveness.

Keyphrases

primary care
emergency department
clinical trial
phase iii
decision making
combination therapy
drug delivery
smoking cessation